NF-κB: a key role in inflammatory diseases
Paul P. Tak(Celldex Therapeutics (United States)), Gary S. Firestein(Inflammation Research Foundation)
Cited by 3,875
Related Papers
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
|Nature Genetics|2008|542